Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma

Clinical Lung Cancer

Volumn 13, Issue 4, 2012, Pages 297-303

  Kontic, Milica ^a   Stojsic, Jelena ^a   Jovanovic, Dragana ^a   Bunjevacki, Vera ^a   Ognjanovic, Simona ^b   Kuriger, Jacquelyn ^c   Puumala, Susan ^d   Nelson, Heather H ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

CDH13; Clinicopathologic characteristics; Methylation; MGMT; Non small cell lung carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER TISSUE; CDH13 GENE; CONTROLLED STUDY; CPG ISLAND; DAPK GENE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; ESR1 GENE; FEMALE; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MGMT GENE; PRIMARY TUMOR; PROMOTER REGION; PYROSEQUENCING; RASSF1A GENE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TUMOR SUPPRESSOR GENE;

AGED; APOPTOSIS REGULATORY PROTEINS; CADHERINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; SEX FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84861606400     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.11.003     Document Type: Article

References (20)

1. A. Jemal, T. Murray, A. Samuels Cancer statistics, 2003 CA Cancer J Clin 53 2003 5 26 (Pubitemid 36163619)
2. J.S. Kim, J. Han, Y.M. Shim Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma Cancer 104 2005 1825 1833 (Pubitemid 41513164)
3. K. Saito, K. Kawakami, I. Matsumoto Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer Clin Cancer Res 16 2010 2418 2426
4. D.S. Shames, J.D. Minna, A.F. Gazdar Methods for detecting DNA methylation in tumors: from bench to bedside Cancer Lett 251 2007 187 198 (Pubitemid 46669792)
5. W.L. Chang, M.J. Pan Amplification of Ehrlichia platys DNA from blood specimens by two-step PCR J Clin Immunol 34 1996 3142 3146
6. M.V. Brock, C.M. Hooker, E. Ota-Machida DNA methylation markers and early recurrence in stage I lung cancer N Engl J Med 358 2008 1118 1128 (Pubitemid 351398486)
7. K.O. Toyooka, S. Toyooka, A.K. Virmani Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas Cancer Res 61 2001 4556 4560 (Pubitemid 32685789)
8. M. van Engeland, G.M. Roemen, M. Brink K-ras mutations and RASSF1A promoter methylation in colorectal cancer Oncogene 21 2002 3792 3795 (Pubitemid 34620542)
9. M. van Engeland, M.P. Weijenberg, G.M. Roemen Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer Cancer Res 63 2003 3133 3137 (Pubitemid 36735864)
10. L. Buckingham, L. Penfield Faber, A. Kim PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients Int J Cancer 126 2010 1630 1639
11. J.A. Tsou, L.Y. Shen, K.D. Siegmund Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung Lung Cancer 47 2005 193 204 (Pubitemid 40082162)
12. S. Zöchbauer-Müller, K.M. Fong, A.K. Virmani Aberrant promoter methylation of multiple genes in non-small cell lung cancers Cancer Res 61 2001 249 255 (Pubitemid 32095725)
13. S. Toyooka, R. Maruyama, K.O. Toyooka Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer Int J Cancer 103 2003 153 160 (Pubitemid 35461506)
14. C.J. Marsit, D.H. Kim, M. Liu Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence Int J Cancer 114 2005 219 223 (Pubitemid 40194289)
15. S. Toyooka, K.O. Toyooka, R. Maruyama DNA methylation profiles of lung tumors Mol Cancer Ther 1 2001 61 67
16. T. Vaissière, R.J. Hung, D. Zaridze Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors Cancer Res 69 2009 243 252
17. S. Jahr, H. Hentze, S. Englisch DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells Cancer Res 61 2001 1659 1665 (Pubitemid 34292602)
18. Y. Zhang, R. Wang, H. Song Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer Cancer Lett 303 2011 21 28
19. B. Sarter, T.I. Long, W.H. Tsong Sex differential in methylation patterns of selected genes in Singapore Chinese Hum Genet 117 2005 402 403 (Pubitemid 41194568)
20. L. Van der Weyden, D.J. Adams The Ras-association domain family (RASSF) members and their role in human tumourigenesis Biochim Biophys Acta 1776 2007 58 85 (Pubitemid 47332074)